Pfizer to sell Viagra online to compete with fraudsters

May 8, 2013 | Regulation

Pfizer is to sell its patented Viagra drug online for the first time, as the drugs maker looks to counter the trade in counterfeit pills. The move will see Pfizer sell the erectile disfunction treatment to patients in the US with a valid prescription for $25 each from its website, Viagra.com. The pill will cost […]

Pfizer is to sell its patented Viagra drug online for the first time, as the drugs maker looks to counter the trade in counterfeit pills.


The move will see Pfizer sell the erectile disfunction treatment to patients in the US with a valid prescription for $25 each from its website, Viagra.com.
The pill will cost significantly more than fake versions, but Pfizer said patients would be guaranteed quality.
Pfizer’s patents give it the exclusivity on Viagra until 2020 in the US and for many years after that in other countries.
Some counterfeit versions had been found to contain printer ink and pesticides, the company said.
Pfizer will offer three free tablets with a first order and 30% off the price of a second.
Previously, drugs makers have not sold directly to patients, selling instead to wholesalers which distribute the drugs to doctors, hospitals and pharmacies.
If Pfizer’s move is successful, other drugs companies could follow suit with everything from popular diet pills to sleeping aids.
Drop in sales
In 2000, Viagra accounted for 90% of all ED pill sales but it has been hurt by the arrival of rivals including Cialis and Levitra and an explosion in counterfeit sales worldwide.
Last month, Pfizer said Viagra sales had fallen 7% in the first three months of the year, to $461m.
“There are almost 24 million searches a year for Viagra online,” said Victor Clavelli, senior director of Pfizer’s primary care business unit. “By offering men with ED convenient access and a legitimate alternative to purchase Viagra online, our hope is that Pfizer will help rein in the distribution of fake ED products.”
Matthew Bassiur, Pfizer’s vice-president for global security, said: “We have seen counterfeit medicines manufactured in filthy and deplorable conditions, yet some people do not realize the risks that this poses to their health and safety, our top priority. Counterfeit medicines often contain the wrong or incorrect levels of active ingredient, as well as potentially dangerous contaminants. Samples of counterfeit Viagra tested by our labs have contained pesticides, wallboard, commercial paint and printer ink. These findings motivate us to continue our aggressive global efforts to stop those who prey on unsuspecting patients.”
In 2011, Pfizer conducted chemical analysis of pills advertised as “Pfizer’s Viagra” and bought from 22 websites that appeared in the top search results for the phrase “buy Viagra”.
The study found that about 80% of these pills were counterfeit; although such pills contained Viagra’s active ingredient, sildenafil citrate, the amount was only 30% to 50% of what was advertised.